Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related vascular thrombosis with microvascular injury and its consequences.
抑制補體因子 C5a 或 C5aR 對膽固醇結晶栓塞相關血管血栓形成及其微血管損傷後果的影響。
Kidney Int 2024-08-14
ADAMTS7-Mediated Complement Factor H Degradation Potentiates Complement Activation to Contributing to Renal Injuries.
ADAMTS7介導的補體因子H降解增強補體活化,導致腎損傷。
J Am Soc Nephrol 2024-02-02
The complement C3a and C5a signaling in renal diseases: a bridge between acute and chronic inflammation.
腎臟疾病中補體C3a和C5a信號傳遞:急性與慢性發炎之間的橋樑。
Nephron 2024-03-07
COMPLEMENT-MEDIATED THROMBOTIC MICROANGIOPATHY AFTER KIDNEY TRANSPLANT: SHOULD TREATMENT WITH C5 INHIBITOR BE LIFELONG?
腎移植後補體介導的血栓性微血管病變:是否應該終身使用 C5 抑製劑治療?
Nephron 2024-04-14